Key Takeaways
- • Tiger Global completed just 44 deals in Q3 2022, down 58% from 136 deals in Q1 2022, signaling a dramatic collapse in dealmaking velocity after the firm dominated venture capital in 2021.
- • Coatue Management's deal count fell to 10 in Q3 2022 from a peak of 51 in Q4 2021, representing an 80% decline over roughly one year.
- • Tiger Global's total new investment value declined nearly 60% year-over-year as of November 10, 2022, while Coatue's deal value fell by approximately 67%, demonstrating significant portfolio contraction across both firms.
- • Traditional VCs view the retreat of crossover hedge funds as validation that external capital managers lack sufficient understanding of venture-capital fundamentals, with Tribeca Venture Partners' Brian Hirsch noting Tiger is "conspicuously missing from deal announcements" in 2022.
- • The pullback ends a 2021 dealmaking bonanza when Tiger and Coatue aggressively pursued early-stage investments and upended traditional VC models through speed and capital availability.
Summary
Tiger Global and Coatue Management, the crossover investment firms that catalyzed a venture-capital dealmaking frenzy in 2021, have dramatically retreated from the market in 2022, according to data compiled from PitchBook. The contraction underscores the vulnerability of hedge-fund-backed venture strategies when broader market conditions deteriorate and validates long-standing skepticism within the traditional VC community about external capital managers' ability to navigate sector-specific dynamics.
Tiger Global's deal activity collapsed across the year. The firm completed 136 deals in Q1 2022 but declined to 105 deals in Q2 and further to just 44 deals in Q3, representing a 68% decline from peak quarterly volume. Coatue's trajectory proved even steeper, falling from 51 deals in Q4 2021 to a mere 10 deals in Q3 2022—an 80% contraction over nine months. More significantly, the dollar value of invested capital tells a more sobering story: Tiger's total new investment value dropped nearly 60% year-over-year as of November 10, 2022, while Coatue's deal value declined by approximately 67% over the same period.
Brian Hirsch, a managing partner at Tribeca Venture Partners who frequently coinvested alongside crossover firms, provided direct market evidence of their exit. "I haven't come up against Tiger on a deal at all this year," Hirsch stated, noting that portfolio companies in 2021 actively pursued or entertained competing offers from Tiger and Coatue. By 2022, these firms had become "conspicuously missing from deal announcements." The shift reflects not merely cyclical pullback but structural retrenchment, as traditional VCs contend that crossover firms fundamentally misunderstood venture capital's operational and market dynamics.
The retreat validates a growing consensus among established venture investors that hedge-fund operators, despite commanding substantial capital and execution speed in 2021, lack the domain expertise required for sustained venture investing. What once appeared to be a permanent disruption of traditional VC models—characterized by aggressive term sheets, rapid deployment, and early-stage participation—collapsed as market conditions tightened and portfolio performance deteriorated. The 2022 pullback signals that crossover ventures' venture-capital ambitions have largely failed, leaving traditional VCs to reassert primacy in the sector.
Tiger Global's deal activity collapsed across the year. The firm completed 136 deals in Q1 2022 but declined to 105 deals in Q2 and further to just 44 deals in Q3, representing a 68% decline from peak quarterly volume. Coatue's trajectory proved even steeper, falling from 51 deals in Q4 2021 to a mere 10 deals in Q3 2022—an 80% contraction over nine months. More significantly, the dollar value of invested capital tells a more sobering story: Tiger's total new investment value dropped nearly 60% year-over-year as of November 10, 2022, while Coatue's deal value declined by approximately 67% over the same period.
Brian Hirsch, a managing partner at Tribeca Venture Partners who frequently coinvested alongside crossover firms, provided direct market evidence of their exit. "I haven't come up against Tiger on a deal at all this year," Hirsch stated, noting that portfolio companies in 2021 actively pursued or entertained competing offers from Tiger and Coatue. By 2022, these firms had become "conspicuously missing from deal announcements." The shift reflects not merely cyclical pullback but structural retrenchment, as traditional VCs contend that crossover firms fundamentally misunderstood venture capital's operational and market dynamics.
The retreat validates a growing consensus among established venture investors that hedge-fund operators, despite commanding substantial capital and execution speed in 2021, lack the domain expertise required for sustained venture investing. What once appeared to be a permanent disruption of traditional VC models—characterized by aggressive term sheets, rapid deployment, and early-stage participation—collapsed as market conditions tightened and portfolio performance deteriorated. The 2022 pullback signals that crossover ventures' venture-capital ambitions have largely failed, leaving traditional VCs to reassert primacy in the sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.